R.F.P.M. Kruitwagen

Kessels, I., van Kuijk, S., Vergeldt, T., van Gestel, I., Spaans, W., Notten, K., Kruitwagen, R., & Weemhoff, M. (2025). The External Validation of a Multivariable Prediction Model for Recurrent Pelvic Organ Prolapse After Native Tissue Repair: A Prospective Cohort Study. Journal of Clinical Medicine, 14(2), Article 531. https://doi.org/10.3390/jcm14020531

Vrede, S. W., Van Weelden, W. J., Bulten, J., Gilks, C. B., Teerenstra, S., Huvila, J., Matias-Guiu, X., Gil-Moreno, A., Asberger, J., Sweegers, S., van der Putten, L. J. M., Küsters-Vandevelde, H. V. N., Reijnen, C., Colas, E., Hausnerová, J., Weinberger, V., Snijders, M. P. L. M., Vinklerova, P., Ravaggi, A., ... Pijnenborg, J. M. A. (2025). Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer. Gynecologic Oncology, 192, 15-23. https://doi.org/10.1016/j.ygyno.2024.10.028

Burg, L. C., Vermeulen, R. J., Bekkers, R. L. M., Kruitwagen, R. F. P. M., & Zusterzeel, P. L. M. (2024). The Cost-Effectiveness of Sentinel Lymph Node Mapping in High-Risk Endometrial Cancer. Cancers, 16(24), Article 4240. https://doi.org/10.3390/cancers16244240

van Wagensveld, L., Van Nyen, T., Annibali, D., Sonke, G. S., Kruitwagen, R. F. P. M., Amant, F., & Horlings, H. M. (2024). High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer. Oncologist, 29(9), e1231-e1234. https://doi.org/10.1093/oncolo/oyae161

Ezendam, N. P. M., de Rooij, B. H., Creutzberg, C. L., Kruitwagen, R. F. P. M., van Lonkhuijzen, L. R. P. M., Apperloo, M. J. A., Gerestein, K., Baalbergen, A., Boll, D., Vos, M. C., van de Poll-Franse, L. V., & ENSURE Study Group (2024). Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: The ENSURE randomized controlled trial. Gynecologic Oncology, 188, 169-183. https://doi.org/10.1016/j.ygyno.2024.06.020

Triepels, C. P. R., Boogaard, L. L., Futterer, J. J., van Kuijk, S. M. J., Spaans, W. A., Kruitwagen, R. F. P. M., Weemhoff, M., & Notten, K. J. B. (2024). Explorative Identification of Anatomical Parameters Associated with Successful Pessary Fitting in Pelvic Organ Prolapse Using Dynamic Magnetic Resonance Imaging. Journal of Clinical Medicine, 13(16), Article 4819. https://doi.org/10.3390/jcm13164819

Algera, M. D., van Driel, W. J., Slangen, B. F. M., Wouters, M. W. J. M., Kruitwagen, R. F. P. M., Kruse, A. J., Yigit, R., Engelen, M. J. A., Nooij, L. S., Mens, J. W. M., de Jong, M. A. A., Haverkort, M. A. D., van der Aa, M., Diepstraten, J., van Ham, M. A. P. C., Smedts, H. P. M., Reesink, N., Gaarenstroom, K. N., Vencken, P. M. L. H., ... Dutch Gynecological Oncology Audit Collaborator Group (2024). Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit. Gynecologic Oncology, 186, 144-153. https://doi.org/10.1016/j.ygyno.2024.04.002

van Wagensveld, L., Colomban, O., van der Aa, M. A., Freyer, G., Sonke, G. S., Kruitwagen, R. F. P. M., & You, B. (2024). Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting". Journal of Gynecologic Oncology, 35(3), Article e34. https://doi.org/10.3802/jgo.2024.35.e34